Addison Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.23K Hold
41
﹤0.01% 679
2025
Q4
$8.47K Hold
41
﹤0.01% 648
2025
Q3
$7.35K Hold
41
﹤0.01% 663
2025
Q2
$6.62K Hold
41
﹤0.01% 674
2025
Q1
$6.97K Hold
41
﹤0.01% 633
2024
Q4
$6.82K Hold
41
﹤0.01% 633
2024
Q3
$7.05K Hold
41
﹤0.01% 634
2024
Q2
$6.31K Hold
41
﹤0.01% 610
2024
Q1
$6.3K Hold
41
﹤0.01% 551
2023
Q4
$6.48K Hold
41
﹤0.01% 558
2023
Q3
$6K Hold
41
﹤0.01% 535
2023
Q2
$6.28K Hold
41
﹤0.01% 519
2023
Q1
$6.36K Hold
41
﹤0.01% 494
2022
Q4
$6.32K Hold
41
﹤0.01% 480
2022
Q3
$5K Hold
41
﹤0.01% 503
2022
Q2
$6K Hold
41
﹤0.01% 482
2022
Q1
$6K Hold
41
﹤0.01% 513
2021
Q4
$7K Hold
41
﹤0.01% 443
2021
Q3
$7K Hold
41
0.01% 329
2021
Q2
$7K Buy
+41
New +$6.77K 0.01% 324
2020
Q4
$7K Buy
+41
New +$6.65K 0.01% 309

Other funds holding FBT

Addison Advisors's FBT Position: Q1 2026 in Review

Addison Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 41 shares worth $8.23K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Addison Advisors first reported a position in FBT in Q4 2020 and has held it in 21 quarters since. The position peaked at $8.47K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Addison Advisors held 41 shares of First Trust NYSE Arca Biotechnology Index Fund worth $8.23K as of Q1 2026.
  • Addison Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Addison Advisors's portfolio in Q1 2026, its #679 holding.
  • Addison Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $8.47K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.